English

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

EDGAR

Quarterly report amendment (10-Q/A) · filed 2011-12-07

19 filing records in this dataset, filed from 2008-11-14 to 2011-12-07. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

201 thousand USD

2011 Q3 · USD

Exact inputs and evidence

Revenue: 200711 USD Source

Operating margin

-82.78%

2011 Q3 · %

Exact inputs and evidence

Operating Income: -166143 USD Source
Revenue: 200711 USD Source

Operating cash flow

-7.66 thousand USD

2011 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: -240611 USD Source
Operating Cash Flow: -232954 USD Source

Cash and cash equivalents: 17 thousand USD 2011-09-30 Source
Exact value

17049 USD
Long-term debt including current maturities: 471 thousand USD 2011-09-30 Source
Exact value

471495 USD
Shares outstanding: 32.9 million shares 2011-09-30 Source
Exact value

32863808 shares

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-12-07.

Financial data available through: 2008-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2008-12-31
Operating income: 2 of 11 periods available· newest 2008-12-31
Net income: 2 of 11 periods available· newest 2008-12-31
operating cash flow: No compatible figures in this window
Capital expenditure: 2 of 11 periods available· newest 2008-12-31
assets: No compatible figures in this window
Total liabilities: 2 of 11 periods available· newest 2008-12-31
Current assets: 2 of 11 periods available· newest 2008-12-31
Current liabilities: 2 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 2 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+258.6%

Prior period

USD 326,935

2007-01-01 – 2007-12-31
Current period

USD 1.17 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

1172368 − 326935 = 845433 USD

326935 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
1172368 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2008-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Year-over-year change in Revenue: 845433 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 1172368 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1357 Input fundies:Revenue: 326935 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1357
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 158,649

Prior period

−USD 1.33 million

2007-01-01 – 2007-12-31
Current period

−USD 1.17 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

-1172498 − -1331147 = 158649 USD

-1331147 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-1172498 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2008-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Year-over-year change in Net income: 158649 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1172498 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-10-000080.txt#1793 Input fundies:NetIncome: -1331147 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1630
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+173.4%

Prior period

USD 4,969

2007-01-01 – 2007-12-31
Current period

USD 13,587

2008-01-01 – 2008-12-31

Exact inputs and evidence

13587 − 4969 = 8618 USD

4969 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
13587 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2008-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Year-over-year change in Capital expenditure: 8618 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 13587 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-10-000080.txt#1868 Input fundies:CapitalExpenditure: 4969 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1684
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 1.17 million 100% of revenue
Cost of revenue USD 456,824 39% of revenue
Operating expenses USD 1.87 million 159% of revenue
Operating income −USD 1.15 million −98% of revenue
Tax, interest and other Derived USD 20,182 1.7% of revenue
Net income −USD 1.17 million −100% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure USD 13,587 1.2% of revenue
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 Operating loss: operating costs were 507% of revenue.
2008 Operating loss: operating costs were 198% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2007-01-01 – 2007-12-31	326935	1656554 Derived	-1329619	1528 Derived	-1331147	Unavailable	Source 2007-01-01 – 2007-12-31: 326935 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -1329619 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -1331147 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 4969 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	1172368	2324684 Derived	-1152316	20182 Derived	-1172498	Unavailable	Source 2008-01-01 – 2008-12-31: 1172368 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -1152316 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -1172498 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 13587 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 1.2M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Revenue	326935	Revenue: 326935 Open source
20082008-12-31	Revenue	1172368	Revenue: 1172368 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

258.6% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Year over year	No prior comparable period	Revenue: 326935 Open source
20082008-12-31	Year over year	258.6%	Revenue: 1172368 Open source Revenue: 326935 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -98.3% 2008

Net margin -100% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Operating margin	-406.7%	Operating Income: -1329619 Open source Revenue: 326935 Open source
20082008-12-31	Operating margin	-98.3%	Operating Income: -1152316 Open source Revenue: 1172368 Open source
20072007-12-31	Net margin	-407.2%	Net Income: -1331147 Open source Revenue: 326935 Open source
20082008-12-31	Net margin	-100%	Net Income: -1172498 Open source Revenue: 1172368 Open source
20072007-12-31	Free cash flow margin	Not reported	Revenue: 326935 Open source Capital Expenditure: 4969 Open source
20082008-12-31	Free cash flow margin	Not reported	Revenue: 1172368 Open source Capital Expenditure: 13587 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Operating cash flow	Not reported	No source recorded
20082008-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-12-31	Free cash flow	Unavailable	Capital Expenditure: 4969 Open source
20082008-12-31	Free cash flow	Unavailable	Capital Expenditure: 13587 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Liabilities / assets	Not reported	Total Liabilities: 311323 Open source
20082008-12-31	Liabilities / assets	Not reported	Total Liabilities: 1127568 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.2× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-12-31	Current assets / current liabilities	1.41×	Current Assets: 440154 Open source Current Liabilities: 311323 Open source
20082008-12-31	Current assets / current liabilities	1.2×	Current Assets: 789724 Open source Current Liabilities: 656073 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2007-01-01 – 2007-12-31	−USD 1.33 million Exact value Exact value: -1331147 USD 2007-01-01 – 2007-12-31: -1331147 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2007-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Net Income: -1331147 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1331147 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1630 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 4,969 Exact value Exact value: 4969 USD 2007-01-01 – 2007-12-31: 4969 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2007-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Capital Expenditure: 4969 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4969 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-09-000044.txt#1684 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.
2008 2008-01-01 – 2008-12-31	−USD 1.17 million Exact value Exact value: -1172498 USD 2008-01-01 – 2008-12-31: -1172498 USD Inspect Net Income Open source Share or cite Citation for Net Income · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2008-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Net Income: -1172498 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1172498 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-10-000080.txt#1793 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	USD 13,587 Exact value Exact value: 13587 USD 2008-01-01 – 2008-12-31: 13587 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC · 2008-12-31 BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC (edgar:1443062) Capital Expenditure: 13587 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T17:15:40Z Snapshot: 1636ff16f8d542b9d5511d46e98014b58ce935497881749ec74dc9c65e593eb2 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1443062/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 13587 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1443062/0001011034-10-000080.txt#1868 The citation records this snapshot. The page link may show a newer release later.	Unavailable Free cash flow cannot be calculated because Operating cash flow is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

19 filings · 249 latest values · 249 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001443062, 1443062, edgar:1443062

Also known as BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Company performance

What changed year over year

Revenue

Net income

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation